These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9389570)
1. Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line. Van Waardenburg RC; Meijer C; Burger H; Nooter K; De Vries EG; Mulder NH; De Jong S Int J Cancer; 1997 Nov; 73(4):544-50. PubMed ID: 9389570 [TBL] [Abstract][Full Text] [Related]
2. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061 [TBL] [Abstract][Full Text] [Related]
3. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728 [TBL] [Abstract][Full Text] [Related]
4. Effect of cisplatin exposure on the degree of N-myc amplification in small cell lung carcinoma cell lines with N-myc amplification. Mizushima Y; Kashii T; Kobayashi M Oncology; 1996; 53(5):417-21. PubMed ID: 8784478 [TBL] [Abstract][Full Text] [Related]
5. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866 [TBL] [Abstract][Full Text] [Related]
6. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense]. Peng X; Feng F; Zhang W Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759 [TBL] [Abstract][Full Text] [Related]
7. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Akie K; Dosaka-Akita H; Murakami A; Kawakami Y Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):243-9. PubMed ID: 10984118 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression. Weber E; Ravi RK; Knudsen ES; Williams JR; Dillehay LE; Nelkin BD; Kalemkerian GP; Feramisco JR; Mabry M Int J Cancer; 1999 Mar; 80(6):935-43. PubMed ID: 10074929 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif. Nishino K; Osaki T; Kumagai T; Kijima T; Tachibana I; Goto H; Arai T; Kimura H; Funakoshi T; Takeda Y; Tanio Y; Hayashi S Int J Cancer; 2001 Mar; 91(6):851-6. PubMed ID: 11275991 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. Mizutani Y; Fukumoto M; Bonavida B; Yoshida O Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365 [TBL] [Abstract][Full Text] [Related]
12. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. Barr LF; Campbell SE; Bochner BS; Dang CV Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091 [TBL] [Abstract][Full Text] [Related]
13. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. Li S; Bao P; Li Z; Ouyang H; Wu C; Qian G Oncol Rep; 2009 May; 21(5):1243-9. PubMed ID: 19360300 [TBL] [Abstract][Full Text] [Related]
15. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines. Xie XK; Yang DS; Ye ZM; Tao HM Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588 [TBL] [Abstract][Full Text] [Related]
16. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells]. Zhang MC; Hu CP; Chen Q Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483 [TBL] [Abstract][Full Text] [Related]
17. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo. Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. Tsurutani J; Soda H; Oka M; Suenaga M; Doi S; Nakamura Y; Nakatomi K; Shiozawa K; Amada YY; Kamihira S; Kohno S Int J Cancer; 2003 Mar; 104(2):238-42. PubMed ID: 12569581 [TBL] [Abstract][Full Text] [Related]
19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
20. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements. Kumagai T; Tanio Y; Osaki T; Hosoe S; Tachibana I; Ueno K; Kijima T; Horai T; Kishimoto T Cancer Res; 1996 Jan; 56(2):354-8. PubMed ID: 8542591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]